Assuming strategy is required, the following results were found.

  • A Boster video: Simplified Strategy to Better Care for People with Multiple Sclerosis (Part 1)

    In this video I share a simplified strategy to help Neurologists better care for people impacted by Multiple Sclerosis! A Four-to-Four Approach Wanna learn how? Then start watching this video right now! An awesome video. Remember to share with friends...

    https://mschristian.org/index.php/articles/2-uncategorised/9552-a-boster-video-simplified-strategy-to-better-care-for-people-with-multiple-sclerosis-part-1
  • "Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction"

    Both the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management. By: Aaron Boster, MD Published: December 02, 2019 As the field of neuroimmunology evolves at an unprecedented rate, keeping up with the latest...

    https://mschristian.org/index.php/articles/2-uncategorised/9438-treating-ms-a-simplified-strategy-boosts-patient-and-provider-satisfaction
  • A Boster video: Simplified Strategy to Better Care for People with Multiple Sclerosis (Part 1)

    In this video I share a simplified strategy to help Neurologists better care for people impacted by Multiple Sclerosis! A Four-to-Four Approach Wanna learn how? Then start watching this video right now! An awesome video. Remember to share with friends...

    https://mschristian.org/index.php/blog/a-boster-video-simplified-strategy-to-better-care-for-people-with-multiple-sclerosis-part-1
  • Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2 - Science

    on a Symphony A5 flow cytometer (BD Biosciences) and analyzed using FlowJo (FlowJo LLC, Ashland, OR, USA). The gating strategy is shown in fig. S13. Immunoblotting Immunoblotting was carried out as previously described (1) and analyzed using either a...

    https://mschristian.org/index.php/blog/severe-type-i-interferonopathy-and-unrestrained-interferon-signaling-due-to-a-homozygous-germline-mutation-in-stat2-science
  • Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2 - Science

    on a Symphony A5 flow cytometer (BD Biosciences) and analyzed using FlowJo (FlowJo LLC, Ashland, OR, USA). The gating strategy is shown in fig. S13. Immunoblotting Immunoblotting was carried out as previously described (1) and analyzed using either a...

    https://mschristian.org/index.php/articles/2-uncategorised/9542-severe-type-i-interferonopathy-and-unrestrained-interferon-signaling-due-to-a-homozygous-germline-mutation-in-stat2-science
  • "Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction"

    Both the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management. By: Aaron Boster, MD Published: December 02, 2019 As the field of neuroimmunology evolves at an unprecedented rate, keeping up with the latest...

    https://mschristian.org/index.php/blog/treating-ms-a-simplified-strategy-boosts-patient-and-provider-satisfaction
  • What's New in Stem Cells? Expert Discusses Hematopoietic Status and Newer Mesenchymal Approaches

    expert in stem cell therapeutics.Stem cell treatments (SCT) have been described as a promising and powerful therapeutic strategy for severe multiple sclerosis (MS), a highly experimental approach, or a dubious sham treatment preying on unwary patients....

    https://mschristian.org/index.php/what-s-new-in-stem-cells-expert-discusses-hematopoietic-status-and-newer-mesenchymal-approaches
  • COVID-19 and Neuromyelitis Optica Disorder: A Need for Guidance-Based Management - Neurology Advisor

    guidance indicates the need for more rigorous observational study in these patients to determine an appropriate management strategy. The authors wrote that additional information gleaned from this research “will be crucial for patients and clinicians to...

    https://mschristian.org/index.php/blog/covid-19-and-neuromyelitis-optica-disorder-a-need-for-guidance-based-management-neurology-advisor
  • Cortica Announces Leadership Appointments And Strategic Investment By Ajax Health And Questa Capital - P&T Community

    With over 15 years of healthcare technology experience, Mr. Nathan is responsible for leading Cortica's overall digital strategy and services, including electronic health records, software development, analytics, and information security. He previously...

    https://mschristian.org/index.php/articles/2-uncategorised/9752-cortica-announces-leadership-appointments-and-strategic-investment-by-ajax-health-and-questa-capital-p-t-community
  • U.K. vapor industry asks government to keep vape shops open

    open across the country, rather than forcing them to close as part of any intensification of its coronavirus containment strategy. Closing vapes stores, the industry argues, would be a potentially counterproductive move that could place further strain...

    https://mschristian.org/index.php/articles/2-uncategorised/10353-u-k-vapor-industry-asks-government-to-keep-vape-shops-open
  • My Top 3 Drug Stocks to Buy in the Market Crash - The Motley Fool

    $7 billion annually, but competition from biosimilars and other new drugs has halved that figure. New CEO Paul Hudson's strategy involves a shift into higher growth areas. He ended Sanofi's diabetes and cardiovascular research, and in January, Sanofi...

    https://mschristian.org/index.php/blog/my-top-3-drug-stocks-to-buy-in-the-market-crash-the-motley-fool
  • An important clue on the role of diet in MS?

    progression. But yet, there is still much work to be done. There is conflicting evidence on which, if any, dietary strategy works best to prevent and treat MS, and doctors generally remain extremely skeptical of lifestyle-based interventions. One of the...

    https://mschristian.org/index.php/blog/an-important-clue-on-the-role-of-diet-in-ms
  • Paul Mirabella Joins CorTechs Labs' Board of Directors - Business Wire

    years, will play an active role in advising CorTechs Labs on matters including, but not limited to, business development strategy as well as product development and enhancement. Mr. Mirabella is currently president and chief executive officer (CEO) of...

    https://mschristian.org/index.php/blog/paul-mirabella-joins-cortechs-labs-board-of-directors-business-wire
  • NetNoggin® releases exploratory analysis "Healthcare Provider Needs in the NASH Market" - P&T Community

    companies change secondary endpoints in late phase clinical trials and align them to their commercialization strategy. A sneak peek of the NetNog: #genesis® NASH (including NAFL) research report is in the appendix of the exploratory analysis. FREDERICK,...

    https://mschristian.org/index.php/blog/netnoggin-releases-exploratory-analysis-healthcare-provider-needs-in-the-nash-market-p-t-community
  • Handling Stress - Mind-Body Basics for People with MS

    to see what works for you. Want to Give Mind-Body Therapy a Try? Start Here “We don’t know that there’s one mind-body strategy that works better than all the others, so it’s important that people figure out what feels good to them,” Zackowski says....

    https://mschristian.org/index.php/blog/handling-stress-mind-body-basics-for-people-with-ms
  • #ECTRIMS2019 – Tysabri During Pregnancy and After Delivery Seems Safe, Reduces Relapse Risk, Study Finds

    said more data was needed. They sought to confirm Tysabri’s safety and efficacy, and to find the best management strategy for women taking this medicine who plan to become mothers. The team therefore analyzed data from a group of 86 pregnant women with...

    https://mschristian.org/index.php/blog/ectrims2019-tysabri-during-pregnancy-and-after-delivery-seems-safe-reduces-relapse-risk-study-finds
  • NervGen Pharma readies trials for biologic treatment of spinal cord injury, multiple sclerosis - Becker's Orthopedic & Spine

    of spinal cord injury, multiple sclerosis Becker's Orthopedic & Spine NervGen Pharma is planning its clinical development strategy for its compound, NVG-291, in spinal cord injury and multiple sclerosis patients. Original link NervGen Pharma readies...

    https://mschristian.org/index.php/blog/nervgen-pharma-readies-trials-for-biologic-treatment-of-spinal-cord-injury-multiple-sclerosis-becker-s-orthopedic-spine
  • Small Study Finds that a Diet that Improves Cholesterol Levels May Reduce MS-Related Fatigue

    weight also led to reductions in MS-related fatigue.If results are confirmed by larger studies, this may offer another strategy for treating MS fatigue. At least one follow-up study is underway.Dr. Kelly Fellows Maxwell and others at State University of...

    https://mschristian.org/index.php/blog/small-study-finds-that-a-diet-that-improves-cholesterol-levels-may-reduce-ms-related-fatigue
  • Experts Confident Biden’s COVID-19 Response Could Speed Recovery

    distancing practices — something not necessarily seen nationwide right now. “I think what we’ve seen in the Biden campaign strategy, something I certainly will support and echo, is that really two of the biggest challenges have been supply chains...

    https://mschristian.org/index.php/experts-confident-biden-s-covid-19-response-could-speed-recovery
  • Don't Skip Opiates for ‘Air Hunger’ From COVID-19 Ventilation

    they argued. For instance, only 60% of ARDS patients in the ALVEOLI trial got opioids as part of their initial sedation strategy. The rate was 55% in a small meta-analysis of ARDS studies. "There has been a tendency to equate 'sedation' with an...

    https://mschristian.org/index.php/don-t-skip-opiates-for-air-hunger-from-covid-19-ventilation

Results 1 - 20 of 42